World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 23 October 2023
Main ID:  ISRCTN18093885
Date of registration: 28/09/2016
Prospective Registration: No
Primary sponsor: Region Västra Götaland
Public title: Measurement of cervical length with vaginal ultrasound in midgestation in asymptomatic women with a singleton pregnancy to predict preterm delivery
Scientific title: Measurement of cervical length with vaginal ultrasound in the second trimester in asymptomatic women with a singleton pregnancy to predict preterm delivery: a Swedish multi-center observational study
Date of first enrolment: 01/05/2014
Target sample size: 11000
Recruitment status: Completed
URL:  https://www.isrctn.com/ISRCTN18093885
Study type:  Observational
Study design:  Multicentre prospective observational study (Screening)  
Phase:  Not Applicable
Countries of recruitment
Sweden
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name: Ulla-Britt    Wennerholm
Address:  Sahlgrenska Universitetssjukhuset, Östra 41685 Göteborg Sweden
Telephone: +46313435580
Email: ulla-britt.wennerholm@vgregion.se
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria:
1. Asymptomatic women > 18 years old
2. With a live healthy singleton pregnancy in gestational week 18+0-20+6
3. Able to understand oral and written information

Exclusion criteria:
1. Fetal malformation
2. Rupture of membranes
3. Current vaginal bleeding
4. Ongoing miscarriage
5. Cerclage in situ
6. Current progesterone treatment at the time of recruitment


Age minimum:
Age maximum:
Gender: Female
Health Condition(s) or Problem(s) studied
Pregnancy
Pregnancy and Childbirth
Intervention(s)

This is a Swedish multicentre prospective observational study. where healthy asymptomatic women with a singleton pregnancy will be examined with transvaginal ultrasound and measurement of cervical length during midtgestation.

Ultrasound examinations of the cervix are carried out by specially trained midwives, who have undergone standardized theoretical education and practical training. A certification system specially designed for this project is in place. The ultrasound examinations are performed vaginally with the woman in the lithotomy position with an empty urinary bladder. The vaginal ultrasound probe is slowly introduced into the vagina until the cervix becomes visible. Care is taken not to exert undue pressure on the cervix: the anterior and posterior lips of the cervix should appear equally thick. Ideally, the cervical canal should be horizontal in the image. The length of the closed cervical canal ( the line made by the interface of the mucosal surfaces) is measured as a straight line between the internal and external cervical os. If the isthmus is present its length is measured separately. Each measurement is taken three times, and all three are recorded. Images are stored for quality assessment.
These measurements are taken at 18+0-20+6 gestational weeks and 21+0-23+6 gestational weeks.

The women themselves and all medical staff are blinded to the results of the cervical length measurements. However, an ultrasound finding of bulging amniotic membranes is disclosed.
Primary Outcome(s)
Ability of sonographic cervical length to predict preterm birth < 33 weeks, expressed as the area under the receiver operating characteristic curve (ROC) sensitivity, specificity, positive and negative likelhood ratio.
Secondary Outcome(s)

Ability of sonographic cervical length to predict spontaneous PTB <33 + 0 gestational weeks and for total and spontaneous PTB <28 + 0, <29 + 0, <30 + 0, <31 + 0, <32 + 0, <34 + 0 and< 35 + 0 gestational weeks.

All calculations will be made for:
1. the length of the closed cervical canal
2. if the isthmus is present its length is measured separately
3. from the external cervical os to the apparent (virtual) inner cervical os (if isthmus is present)
4. the length of the closed cervical canal + the isthmus.

Each measurement is taken three times and all three are recorded. Calculations will be made for the minimum, maximum and mean value and separately for measurements taken at 18 + 0 - 20 + 6 gestational weeks and 21+ 0 - 23 + 6 gestational weeks. using the ROC curves, the optimal method for measuring cervical length (which week, which measurement) and the optimal cervical length cutoff of the optimal method to predict PTB will be identified. The ability of a change in cervical length between the first (at 18 + 0 - 20 + 6) and the second (at 21 + 0 - 23 + 6) cervical length measurement to predict PTB. The prevalence of "short cervix" (using different definitions) will be calculated.
Secondary ID(s)
2014-10104-117089-114 The Swedish Research Council
Source(s) of Monetary Support
Swedish Research Council, Vetenskapsrådet, Regional R & D Council, Uppsala / Örebro (Regionala FOU rådet Uppsala/Örebro), Centrum fÖr Klinisk Forskning Dalarna, Southern Älvsborg Hospital (SÄS, Forskningsenhet), Regional R & D funds Västra Götaland (VGR Regionala FOU medel), Hjalmar Svensson Research Fund (Handlanden Hjalmar Svensson, Göteborg), Löf (County Councils' Mutual Insurance)
Secondary Sponsor(s)
Ethics review
Status:
Approval date:
Contact:
Old ethics approval format; Ethical committee at University of Gothenburg, Sweden, 13/11/2013 (ref: 825-13), 17/01/2014 (ref: T053-14), 08/12/2015 (ref: T972-15) and 25/02/2016 (ref: T122-16)
Results
Results available: Yes
Date Posted:
Date Completed: 01/11/2017
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history